BioSante Pharmaceuticals first-quarter net loss increases to $10.5 million

by admin on May 14, 2010

BioSante Pharmaceuticals, Inc. today reported on its recent developments and financial results for the first quarter, and its cash balance as of March 31, 2010.

Previous post: Hayes, Inc. Releases Guide to BRCA1 and BRCA2 Genetic Testing - PR Web (press release)

Next post: Hayes, Inc. Releases Guide to BRCA1 and BRCA2 Genetic Testing